Nevertheless, strategies to overcome such limitations are under development and several preclinical studies employing adenoviral vectors with therapeutic genes, ING4 (inhibitor of growth family) [46], IL-24 [47] or TK [48] have shown different degrees of success in pancreatic cancer models. The gene discussed is TKT; the disease is pancreatic neoplasm.